Biblio
CD200 expression marks leukemia stem cells in human AML. Blood Adv. 2020;4(21):5402-5413.
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.